Search results for "Cirrhosis"


 
Results 81 - 90 of about 123 for "Cirrhosis".
Sort by: Relevance | Newest | Oldest

MKSAP Quiz: Chronic pain and a history of cirrhosis

This month's quiz asks readers to determine the most appropriate treatment for a 66-year-old patient with chronic back pain and a history of cirrhosis, osteoporosis, and stage 2 chronic kidney disease.
https://gastroenterology.acponline.org/archives/2022/02/25/4.htm
25 Feb 2022

U.S. sees decrease in HCC disease burden

Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022

AGA clinical practice update offers guidance on PPI deprescribing

All patients taking a proton-pump inhibitor (PPI) should have a regular review and documentation of ongoing indications for use, which should be the responsibility of the primary care clinician, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/02/25/6.htm
25 Feb 2022

Pickle juice reduced cramp severity in patients with cirrhosis

A small trial randomized 82 patients with cirrhosis and frequent muscle cramps to drink either a sip of pickle brine or tap water when they developed cramps and found a significant reduction in cramp severity scores in the former group.
https://gastroenterology.acponline.org/archives/2022/04/22/3.htm
22 Apr 2022

Noninvasive score for fibrotic NASH designed for, validated in primary care settings

Levels of aspartate aminotransferase, high-density lipoprotein cholesterol, and HbA1c can be used to predict which patients might need referral to a subspecialist for fibrotic nonalcoholic steatohepatitis (NASH).
https://gastroenterology.acponline.org/archives/2022/04/22/1.htm
22 Apr 2022

Spotlight on NAFLD outcomes

Recent studies found associations between nonalcoholic fatty liver disease (NAFLD) and coronary artery disease, sarcopenia, and mortality.
https://gastroenterology.acponline.org/archives/2022/05/27/5.htm
27 May 2022

A click to improve cirrhosis care

An electronic alert increased use of rifaximin in patients with cirrhosis who were taking lactulose and were admitted with hepatic encephalopathy.
https://gastroenterology.acponline.org/archives/2022/06/24/7.htm
24 Jun 2022

HCV medications decreased liver disease among those using injection drugs

A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022

Fatty liver disease may not affect mortality risk in elderly patients

In a Dutch cohort study of patients ages 65 years and older, no association was found between hepatic steatosis and death in the overall population or in clinically relevant subgroups.
https://gastroenterology.acponline.org/archives/2022/07/22/3.htm
22 Jul 2022

Spotlight on hospital care for cirrhosis

In recent studies of patients with cirrhosis, an admission order set was associated with better care quality, data supported culture-based deescalation of antibiotics during hospitalization, and nonvariceal upper GI bleeding was associated with higher readmission rates.
https://gastroenterology.acponline.org/archives/2022/08/26/5.htm
26 Aug 2022

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next